• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

BioMedPartners

edit

BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.

Recent Milestones

edit

• 
  BioMedPartners invested in SuppreMol. (5/21/13)
  Posted 5/21/13 at 7:12pm via dowjones.com
• 
  BioMedPartners invested in Activaero. (2/16/11)
  Posted 2/16/11 at 6:15pm via cnbc.com
• 
  BioMedPartners invested in SuppreMol. (12/17/10)
  Posted 12/19/10 at 6:56pm via finsmes.com
• 
  BioMedPartners invested in Curetis. (12/3/09)
  Posted 12/3/09 at 5:45pm via curetis.com
• 
  BioMedPartners invested in Activaero. (11/20/09)
  Posted 11/20/09 at 8:24pm via businesswire.com

Investments

Videos

Sources

1. Switzerland, BioMedPartners Closes BioMedInvest II, a CHF106M Venture Capital Fund (finsmes.com) [edit]
2. German Drug Developer SuppreMol Adds EUR9.5M to Series D (pevc.dowjones.com) [edit]
3. Activaero Raises EUR 5.0 Million ($ 6.8 Million) In a Second Closing Series a Round Led By LSP (cnbc.com) [edit]
4. SuppreMol Closes €15.5M Series C Financing Round (finsmes.com) [edit]
5. € 18.5 million Series A Financing Round closed (curetis.com) [edit]
6. Activaero, GmbH: Series A $15.9M (businesswire.com) [edit]